Strategies for recombinant allergen vaccines and fruitful results from first clinical studies

被引：20

作者：

Cromwell, Oliver ^{[1
]}

Fiebig, Helmut ^{[1
]}

Suck, Roland ^{[1
]}

Kahlert, Helga ^{[1
]}

Nandy, Andreas ^{[1
]}

Kettner, Jens ^{[1
]}

Narkus, Annemle ^{[1
]}

机构：

[1] Allergopharma Joachim Ganzer KG, Res & Dev, D-21465 Reinbek, Germany

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2006年 / 26卷 / 02期

关键词：

D O I：

10.1016/j.iac.2006.02.001

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 [免疫学];

摘要：

Recombinant DNA technology has delivered the prospect of a new generation of preparations for allergen-specific immunotherapy. The first clinical studies with recombinant allergens have yielded encouraging results, suggesting that there is a good chance that such preparations will become available for use in the routine management of allergic disease.

引用

页码：261 / +

页数：22

共 54 条

[1]

Regulation of specific immune responses by chemical and structural modifications of allergens [J].

Akdis, CA ;

Blaser, K .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2000, 121 (04) :261-269

[2]

Characteristics and immunobiology of grass pollen allergens [J].

Andersson, K ;

Lidholm, J .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2003, 130 (02) :87-107

[3]

Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen [J].

Arquint, O ;

Helbling, A ;

Crameri, R ;

Ferreira, F ;

Breitenbach, M ;

Pichler, WJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (06) :1239-1243

[4]

Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy [J].

Batard, T ;

Didierlaurent, A ;

Chabre, H ;

Mothes, N ;

Bussières, L ;

Bohle, B ;

Couret, MN ;

Ball, T ;

Lemoine, P ;

Tejkl, MF ;

Chenal, A ;

Clément, G ;

Dupont, F ;

Valent, P ;

Krauth, MT ;

André, C ;

Valenta, R ;

Moingeon, P .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (03) :239-249

[5]

Prevalence and rate of diagnosis of allergic rhinitis in Europe [J].

Bauchau, V ;

Durham, SR .

EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (05) :758-764

[6]

Engineered allergens for immunotherapy [J].

Bhalla, Prem L. ;

Singh, Mohan B. .

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (06) :569-573

[7]

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid [J].

Corrigan, CJ ;

Kettner, J ;

Doemer, C ;

Cromwell, O ;

Narkus, A .

ALLERGY, 2005, 60 (06) :801-807

[8]

DISPLAY OF EXPRESSION PRODUCTS OF CDNA LIBRARIES ON PHAGE SURFACES - A VERSATILE SCREENING SYSTEM FOR SELECTIVE ISOLATION OF GENES BY SPECIFIC GENE-PRODUCT LIGAND INTERACTION [J].

CRAMERI, R ;

JAUSSI, R ;

MENZ, G ;

BLASER, K .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 226 (01) :53-58

[9]

Recombinant Aspergillus fumigatus allergens:: From the nucleotide sequences to clinical applications [J].

Crameri, R .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 115 (02) :99-114

[10]

Transition of recombinant allergens from bench to clinical application [J].

Cromwell, O ;

Suck, R ;

Kahlert, H ;

Nandy, A ;

Weber, B ;

Fiebig, H .

METHODS, 2004, 32 (03) :300-312

← 1 2 3 4 5 6 →